2,3-diphosphoglycerate has been researched along with Hemolysis in 75 studies
2,3-Diphosphoglycerate: A highly anionic organic phosphate which is present in human red blood cells at about the same molar ratio as hemoglobin. It binds to deoxyhemoglobin but not the oxygenated form, therefore diminishing the oxygen affinity of hemoglobin. This is essential in enabling hemoglobin to unload oxygen in tissue capillaries. It is also an intermediate in the conversion of 3-phosphoglycerate to 2-phosphoglycerate by phosphoglycerate mutase (EC 5.4.2.1). (From Stryer Biochemistry, 4th ed, p160; Enzyme Nomenclature, 1992, p508)
2,3-bisphosphoglyceric acid : A bisphosphoglyceric acid that is glyceric acid carrying two phospho substituents at positions 2 and 3.
Hemolysis: The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate the anti-oxidative effect of ethyl pyruvate (EP) and taurine (TAU) on the quality of red blood cells stored at 4±2 ℃, hemolysis, energy metabolism and lipid peroxidation of the red blood cells in the preservation solution were studied at different intervals." | 4.12 | [Effect of Anti-Oxidative of Ethyl Pyruvate and Taurine on the Red Blood Cell Storage at 4 ℃]. ( Gao, SH; Gao, SQ; Ren, LX; Yuan, XY; Zhu, CH, 2022) |
| " The hemolysis index, lactate and potassium concentrations, prothrombin time (PT), activated partial thromboplastin time (aPTT), and fibrinogen were measured on plasma aliquots." | 3.88 | In vitro assessment of quality of citrate-phosphate-dextrose-adenine-1 preserved feline blood collected by a commercial closed system. ( Bozzato, E; Capello, K; Carminato, A; Corrò, M; Crestani, C; Cro, A; Mutinelli, F; Stefani, A; Vascellari, M, 2018) |
| " RBC units were assessed using an extensive panel of in vitro tests, encompassing regulated quality control criteria such as hematocrit (Hct), hemolysis, and hemoglobin (Hb) levels, as well as adenosine triphosphate, 2,3-diphosphoglycerate, extracellular K(+) and Na(+) levels, methemoglobin, p50, RBC indices, and morphology." | 3.80 | A quality monitoring program for red blood cell components: in vitro quality indicators before and after implementation of semiautomated processing. ( Acker, JP; Croteau, I; Hansen, AL; Jenkins, C; Kurach, JD; Turner, TR, 2014) |
| " Variables analyzed included pH, PCV, and% hemolysis, and lactate, glucose, potassium, sodium, ATP, and 2,3-diphosphoglycerate (2,3-DPG) concentrations." | 3.80 | Effects of four additive solutions on canine leukoreduced red cell concentrate quality during storage. ( Back, FP; González, FH; Hlavac, NR; Jane Wardrop, K; Lacerda, LA; Terra, SR, 2014) |
| " The addition of AGE significantly inhibited an increase in thiobarbituric acid-reactive substances (TBARS) and hemolysis rate and prevented the loss of intraerythrocytic ATP and 2,3-diphosphoglycerate (2,3-DPG) in oxidized erythrocytes." | 3.71 | The effects of aged garlic extract on lipid peroxidation and the deformability of erythrocytes. ( Itakura, Y; Moriguchi, T; Takasugi, N, 2001) |
| " Cell function parameters, including red cell indices, pH, methemoglobin, carboxyhemoglobin, osmotic fragility, hemolysis, 2,3-diphosphoglycerate, cholinesterase, ATP, and antigen typing of treated cells were compared to controls." | 3.70 | Seroconversion of type B to O erythrocytes using recombinant Glycine max alpha-D-galactosidase. ( Evans, ML; Harmata, MA; Johnson, SA; Li, CQ; Mitra, MM; Smith, DS; Vosnidou, NC; Walker, JC; Wells, DC, 1998) |
| "To induce anemia experimentally in rats to provide a hematocrit of 30 to 35% and provide data about the physiologic response to anemia during induction and after it is established, two methods were selected: the application of repetitive doses of phenylhydrazine and bleeding." | 3.69 | Physiological response to experimentally induced anemia in rats: a comparative study. ( Alvarez, AI; Diez, C; Fernández-Rojo, F; Prieto, JG; Redondo, PA, 1995) |
| " Hemolysis, ATP, 2,3-diphosphoglycerate (2,3-DPG), glucose, electrolytes, lactate, hematocrit, Hb and pH were quantified weekly." | 3.69 | [Effect of whole blood preparation and leukocyte filtration on storage of erythrocyte concentrates over 42 days]. ( Janetzko, K; Kirchner, H; Klüter, H; Müller-Steinhardt, M, 1997) |
| " In isoosmotic sucrose solutions, the osmotic hemolysis curve is shifted to the left (less fragile) within several hours at 37 degrees C and within several days at 4 degrees C." | 3.66 | Isoosmotic sucrose, adenine, inosine media for preservation of blood. ( Komatsu, Y; Nakao, M; Nakao, T; Sano, K; Sasakawa, S, 1983) |
| "RBC 2,3-diphosphoglycerate acid levels were substantially less after the 24-hour hold compared to after the 8-hour hold (n = 18; p < 0." | 1.37 | Evaluation of the properties of components prepared and stored after holding of whole blood units for 8 and 24 hours at ambient temperature. ( AuBuchon, JP; Heaton, WA; Holme, S; Moroff, G; Pickard, C; Whitley, PH, 2011) |
| "Haemolysis was below the 0·8% U." | 1.37 | Red cell concentrate storage and transport temperature. ( Cardigan, R; Hancock, V; Thomas, S, 2011) |
| "The severe adverse events observed in patients who received hemoglobin based oxygen carriers (HBOCs) were associated with the Ringer's D." | 1.35 | The effects of preserved red blood cells on the severe adverse events observed in patients infused with hemoglobin based oxygen carriers. ( Ragno, G; Valeri, CR, 2008) |
| "Hemolysis was at 0." | 1.33 | Storage of red blood cells with improved maintenance of 2,3-bisphosphoglycerate. ( Högman, CF; Löf, H; Meryman, HT, 2006) |
| "Hemolysis was very low in both systems, 0." | 1.31 | Improved maintenance of 2,3 DPG and ATP in RBCs stored in a modified additive solution. ( Högman, CF; Knutson, F; Lööf, H; Payrat, JM, 2002) |
| "RBC hemolysis was less than 1 percent after 42 days of storage, and no changes in RBC antigens were observed." | 1.31 | Process for the preparation of pathogen-inactivated RBC concentrates by using PEN110 chemistry: preclinical studies. ( Chapman, J; Dzik, W; Lazo, A; Pivacek, L; Purmal, A; Ragno, G; Valeri, CR, 2002) |
| "2,3-Diphosphoglycerate was induced only during the recovery phase of the study and corresponded to a gradual response to hypoxia." | 1.29 | Physiological response to experimentally induced anemia in rats: a comparative study. ( Alvarez, AI; Diez, C; Fernández-Rojo, F; Prieto, JG; Redondo, PA, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (17.33) | 18.7374 |
| 1990's | 19 (25.33) | 18.2507 |
| 2000's | 16 (21.33) | 29.6817 |
| 2010's | 26 (34.67) | 24.3611 |
| 2020's | 1 (1.33) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, SQ | 1 |
| Gao, SH | 1 |
| Zhu, CH | 1 |
| Yuan, XY | 1 |
| Ren, LX | 1 |
| Lelkens, CCM | 1 |
| Lagerberg, JWM | 1 |
| de Korte, D | 6 |
| Sun, K | 1 |
| D'Alessandro, A | 2 |
| Ahmed, MH | 1 |
| Zhang, Y | 1 |
| Song, A | 1 |
| Ko, TP | 1 |
| Nemkov, T | 1 |
| Reisz, JA | 1 |
| Wu, H | 1 |
| Adebiyi, M | 1 |
| Peng, Z | 1 |
| Gong, J | 3 |
| Liu, H | 1 |
| Huang, A | 1 |
| Wen, YE | 1 |
| Wen, AQ | 1 |
| Berka, V | 1 |
| Bogdanov, MV | 1 |
| Abdulmalik, O | 1 |
| Han, L | 1 |
| Tsai, AL | 1 |
| Idowu, M | 1 |
| Juneja, HS | 1 |
| Kellems, RE | 1 |
| Dowhan, W | 1 |
| Hansen, KC | 1 |
| Safo, MK | 1 |
| Xia, Y | 1 |
| Hebbel, RP | 1 |
| Hedlund, BE | 1 |
| Crestani, C | 1 |
| Stefani, A | 1 |
| Carminato, A | 1 |
| Cro, A | 1 |
| Capello, K | 1 |
| Corrò, M | 1 |
| Bozzato, E | 1 |
| Mutinelli, F | 1 |
| Vascellari, M | 1 |
| Smethurst, PA | 1 |
| Jolley, J | 1 |
| Braund, R | 1 |
| Proffitt, S | 1 |
| Lynes, T | 1 |
| Hazell, M | 1 |
| Mellor, P | 1 |
| Ridgwell, K | 1 |
| Procter, S | 1 |
| Griffiths, A | 1 |
| Marinaki, AM | 1 |
| New, HV | 1 |
| Murphy, GJ | 1 |
| Edmondson, D | 1 |
| Cardigan, R | 5 |
| Radwanski, K | 1 |
| Garraud, O | 1 |
| Cognasse, F | 1 |
| Hamzeh-Cognasse, H | 1 |
| Payrat, JM | 4 |
| Min, K | 1 |
| Gulliksson, H | 2 |
| Nordahl-Källman, AS | 1 |
| Hess, JR | 4 |
| Winter, KM | 1 |
| Johnson, L | 1 |
| Kwok, M | 1 |
| Vidovic, D | 1 |
| Hyland, RA | 1 |
| Mufti, N | 1 |
| Erickson, A | 1 |
| Marks, DC | 1 |
| Acker, JP | 1 |
| Hansen, AL | 1 |
| Kurach, JD | 1 |
| Turner, TR | 1 |
| Croteau, I | 1 |
| Jenkins, C | 1 |
| Lacerda, LA | 1 |
| Hlavac, NR | 1 |
| Terra, SR | 1 |
| Back, FP | 1 |
| Jane Wardrop, K | 1 |
| González, FH | 1 |
| Eckstein, M | 1 |
| Zimmermann, R | 3 |
| Roth, T | 1 |
| Hauck-Dlimi, B | 1 |
| Strasser, EF | 2 |
| Xiang, W | 1 |
| Ercis, K | 1 |
| Aydoğan, S | 1 |
| Atayoğlu, AT | 1 |
| Silici, S | 1 |
| Mambrini, G | 1 |
| Mandolini, M | 1 |
| Rossi, L | 1 |
| Pierigè, F | 1 |
| Capogrossi, G | 1 |
| Salvati, P | 1 |
| Serafini, S | 1 |
| Benatti, L | 1 |
| Magnani, M | 1 |
| Meinke, S | 1 |
| Ravizza, A | 1 |
| Larsson, L | 1 |
| Höglund, P | 1 |
| Bontekoe, IJ | 2 |
| van der Meer, PF | 3 |
| Wilsher, C | 1 |
| Garwood, M | 1 |
| Sutherland, J | 1 |
| Turner, C | 1 |
| Liumbruno, G | 1 |
| Grazzini, G | 1 |
| Zolla, L | 1 |
| Burger, P | 1 |
| Korsten, H | 1 |
| Rombout, E | 1 |
| Van Bruggen, R | 1 |
| Verhoeven, AJ | 3 |
| Hauck, B | 1 |
| Oremek, D | 1 |
| Ruppel, R | 1 |
| Troester, B | 1 |
| Eckstein, R | 2 |
| Hornsey, VS | 1 |
| Casey, C | 1 |
| McColl, K | 1 |
| Young, H | 1 |
| Drummond, O | 1 |
| McMillan, L | 1 |
| Morrison, A | 1 |
| Prowse, CV | 1 |
| Moroff, G | 2 |
| AuBuchon, JP | 3 |
| Pickard, C | 1 |
| Whitley, PH | 1 |
| Heaton, WA | 1 |
| Holme, S | 1 |
| Hancock, V | 2 |
| Thomas, S | 2 |
| Weiss, DR | 1 |
| Goehring, J | 1 |
| Weisbach, V | 1 |
| Ringwald, J | 1 |
| Otani, T | 1 |
| Oki, K | 1 |
| Akino, M | 1 |
| Tamura, S | 1 |
| Naito, Y | 1 |
| Homma, C | 1 |
| Ikeda, H | 1 |
| Sumita, S | 1 |
| Hill, HR | 2 |
| Oliver, CK | 2 |
| Lippert, LE | 2 |
| Greenwalt, TJ | 4 |
| Högman, CF | 7 |
| Knutson, F | 1 |
| Lööf, H | 1 |
| Rugg, N | 1 |
| Joines, AD | 1 |
| Gormas, JF | 1 |
| Pratt, PG | 1 |
| Silverstein, EB | 1 |
| Kagen, LR | 1 |
| Simon, T | 1 |
| Brand, A | 1 |
| Lockwood, W | 1 |
| Zanella, A | 1 |
| Adamson, J | 1 |
| Snyder, E | 1 |
| Taylor, HL | 1 |
| Hogman, C | 1 |
| Elfath, MD | 1 |
| Löf, H | 1 |
| Meryman, HT | 1 |
| Niinistö, K | 1 |
| Raekallio, M | 1 |
| Sankari, S | 1 |
| Valeri, CR | 3 |
| Ragno, G | 3 |
| Kleine, M | 1 |
| Korsten, HG | 1 |
| Purdie, A | 1 |
| Wells, RM | 1 |
| Brittain, T | 1 |
| Vora, S | 1 |
| Nakao, M | 1 |
| Nakao, T | 1 |
| Komatsu, Y | 1 |
| Sano, K | 1 |
| Sasakawa, S | 1 |
| McGrath, KM | 1 |
| Collecutt, MF | 1 |
| Gordon, A | 1 |
| Sawers, RJ | 1 |
| Faragher, BS | 1 |
| Beutler, E | 1 |
| West, C | 1 |
| Castro, O | 2 |
| Eichner, ER | 1 |
| Eriksson, L | 5 |
| Debrauwere, J | 2 |
| Högman, AB | 1 |
| Vikholm, K | 1 |
| Stewart, M | 1 |
| Wagner, SJ | 2 |
| Storry, JR | 1 |
| Mallory, DA | 2 |
| Stromberg, RR | 1 |
| Benade, LE | 1 |
| Friedman, LI | 1 |
| Coppola, L | 1 |
| Giunta, R | 1 |
| Verrazzo, G | 1 |
| Luongo, C | 1 |
| Sammartino, A | 1 |
| Vicario, C | 1 |
| Giugliano, D | 1 |
| Redondo, PA | 1 |
| Alvarez, AI | 1 |
| Diez, C | 1 |
| Fernández-Rojo, F | 1 |
| Prieto, JG | 1 |
| Zhang, H | 1 |
| Weir, B | 1 |
| Marton, LS | 1 |
| Macdonald, RL | 1 |
| Bindokas, V | 1 |
| Miller, RJ | 1 |
| Brorson, JR | 1 |
| Waters, SI | 1 |
| Sen, R | 1 |
| Brunauer, LS | 1 |
| Huestis, WH | 1 |
| Müller-Steinhardt, M | 2 |
| Janetzko, K | 1 |
| Kirchner, H | 2 |
| Klüter, H | 1 |
| Poillon, WN | 1 |
| Kim, BC | 1 |
| Solheim, BG | 1 |
| Bergerud, UE | 1 |
| Kjeldsen-Kragh, J | 1 |
| Brosstad, F | 1 |
| Mollnes, TE | 1 |
| Schutz, R | 1 |
| Skripchenko, A | 1 |
| Robinette, D | 1 |
| Cincotta, L | 1 |
| Vosnidou, NC | 1 |
| Johnson, SA | 1 |
| Mitra, MM | 1 |
| Wells, DC | 1 |
| Li, CQ | 1 |
| Evans, ML | 1 |
| Harmata, MA | 1 |
| Walker, JC | 1 |
| Smith, DS | 1 |
| Arun, P | 1 |
| Padmakumaran Nair, KG | 1 |
| Manojkumar, V | 1 |
| Deepadevi, KV | 1 |
| Lakshmi, LR | 1 |
| Kurup, PA | 1 |
| Moriguchi, T | 1 |
| Takasugi, N | 1 |
| Itakura, Y | 1 |
| Pivacek, LE | 1 |
| Cassidy, GP | 1 |
| Purmal, A | 2 |
| Dzik, W | 1 |
| Pivacek, L | 1 |
| Lazo, A | 1 |
| Chapman, J | 2 |
| Pickard, CA | 1 |
| Herschel, LH | 1 |
| Roger, JC | 1 |
| Tracy, JE | 1 |
| Ackerman, S | 1 |
| Beach, KJ | 1 |
| Hennig, H | 1 |
| Schlenke, P | 1 |
| Rittmeyer, IC | 1 |
| Nydegger, UE | 1 |
| Dumaswala, UJ | 1 |
| Oreskovic, RT | 1 |
| Petrosky, TL | 1 |
| Kaiser, M | 1 |
| Scholz, M | 1 |
| Strauss, D | 1 |
| Ericson, A | 1 |
| Reppucci, AJ | 1 |
| Mori, K | 1 |
| Inoue, N | 1 |
| Fujishiro, K | 1 |
| Kikuchi, M | 1 |
| Chiba, S | 1 |
| Hellwig, U | 1 |
| Angué, M | 1 |
| Chatelain, P | 1 |
| Fiabane, S | 1 |
| Domy, M | 1 |
| Guignier, F | 1 |
| Richaud, P | 1 |
| Almaraz, L | 1 |
| García-Sancho, J | 1 |
| Hedlund, K | 1 |
| Wallvik, J | 1 |
| Stus', LK | 1 |
| Loevskiĭ, MM | 1 |
| Lipina, OV | 1 |
| Gordienko, OI | 1 |
| Kuraksa, VM | 1 |
| Reeves, RB | 1 |
| Morin, RA | 1 |
| Martins e Silva, J | 1 |
5 reviews available for 2,3-diphosphoglycerate and Hemolysis
| Article | Year |
|---|---|
Measures of stored red blood cell quality.
Topics: 2,3-Diphosphoglycerate; Adenosine Triphosphate; Blood Preservation; Erythrocytes; Hemolysis; Humans; | 2014 |
Red blood cell storage: the story so far.
Topics: 2,3-Diphosphoglycerate; Adenosine Triphosphate; Anaerobiosis; Anticoagulants; Blood Preservation; Ce | 2010 |
Quality determinants of erythrocyte destined for transfusion.
Topics: 2,3-Diphosphoglycerate; Animals; Blood Preservation; Erythrocyte Transfusion; Erythrocytes; Hemolysi | 2004 |
Isozymes of phosphofructokinase.
Topics: 2,3-Diphosphoglycerate; Adenosine Triphosphate; Animals; Antibodies, Monoclonal; Chromosome Mapping; | 1982 |
[Erythrocyte mechanisms of adaptation to hypoxia in chronic renal insufficiency].
Topics: 2,3-Diphosphoglycerate; Adaptation, Physiological; Adenosine Triphosphate; Anemia; Animals; Diphosph | 1985 |
1 trial available for 2,3-diphosphoglycerate and Hemolysis
| Article | Year |
|---|---|
Production of pathogen-inactivated RBC concentrates using PEN110 chemistry: a Phase I clinical study.
Topics: 2,3-Diphosphoglycerate; ABO Blood-Group System; Adenosine Triphosphate; Adult; Blood Donors; Blood G | 2002 |
69 other studies available for 2,3-diphosphoglycerate and Hemolysis
| Article | Year |
|---|---|
[Effect of Anti-Oxidative of Ethyl Pyruvate and Taurine on the Red Blood Cell Storage at 4 ℃].
Topics: 2,3-Diphosphoglycerate; Adenine; Adenosine Triphosphate; Blood Preservation; Citrates; Erythrocytes; | 2022 |
The effect of prefreeze rejuvenation on postthaw storage of red blood cells in AS-3 and SAGM.
Topics: 2,3-Diphosphoglycerate; Adenine; Adenosine Triphosphate; Blood Preservation; Erythrocytes; Freezing; | 2017 |
Structural and Functional Insight of Sphingosine 1-Phosphate-Mediated Pathogenic Metabolic Reprogramming in Sickle Cell Disease.
Topics: 2,3-Diphosphoglycerate; Anemia, Sickle Cell; Animals; Erythrocytes, Abnormal; Female; Hemoglobin A; | 2017 |
Sickle hemoglobin oxygen affinity-shifting strategies have unequal cerebrovascular risks.
Topics: 2,3-Diphosphoglycerate; Anemia, Sickle Cell; Benzaldehydes; Cerebrovascular Circulation; Cerebrovasc | 2018 |
In vitro assessment of quality of citrate-phosphate-dextrose-adenine-1 preserved feline blood collected by a commercial closed system.
Topics: 2,3-Diphosphoglycerate; Adenosine Triphosphate; Animals; Blood Cell Count; Blood Preservation; Blood | 2018 |
Rejuvenation of RBCs: validation of a manufacturing method suitable for clinical use.
Topics: 2,3-Diphosphoglycerate; Adenosine Triphosphate; Blood Grouping and Crossmatching; Blood Loss, Surgic | 2019 |
The effects of red blood cell preparation method on in vitro markers of red blood cell aging and inflammatory response.
Topics: 2,3-Diphosphoglycerate; Blood Preservation; Cell-Derived Microparticles; Cells, Cultured; Erythrocyt | 2013 |
Effect of transient warming of red blood cells for up to 24 h: in vitro characteristics in CPD/saline-adenine-glucose-mannitol environment.
Topics: 2,3-Diphosphoglycerate; Adenine; Blood Preservation; Environmental Exposure; Erythrocytes; Glucose; | 2014 |
Red blood cell in vitro quality and function is maintained after S-303 pathogen inactivation treatment.
Topics: 2,3-Diphosphoglycerate; Acridines; Adenosine Triphosphate; Alkylating Agents; Blood Preservation; Bl | 2014 |
A quality monitoring program for red blood cell components: in vitro quality indicators before and after implementation of semiautomated processing.
Topics: 2,3-Diphosphoglycerate; Adenosine Triphosphate; Automation, Laboratory; Blood Banks; Blood Component | 2014 |
Effects of four additive solutions on canine leukoreduced red cell concentrate quality during storage.
Topics: 2,3-Diphosphoglycerate; Adenine; Adenosine Triphosphate; Animals; Blood Preservation; Cell Survival; | 2014 |
The effects of an overnight holding of whole blood at room temperature on haemoglobin modification and in vitro markers of red blood cell aging.
Topics: 2,3-Diphosphoglycerate; Blood Preservation; Erythrocyte Aging; Erythrocytes; Hemoglobins; Hemolysis; | 2015 |
Effect of propolis on erythrocyte rheology in experimental mercury intoxication in rats.
Topics: 2,3-Diphosphoglycerate; Animals; Erythrocytes; Hemolysis; Injections, Intraperitoneal; Leukocyte Cou | 2015 |
Ex vivo encapsulation of dexamethasone sodium phosphate into human autologous erythrocytes using fully automated biomedical equipment.
Topics: 2,3-Diphosphoglycerate; Adenosine Triphosphate; Ataxia Telangiectasia; Automation; Case-Control Stud | 2017 |
Storage of red blood cells in a novel polyolefin blood container: a pilot in vitro study.
Topics: 2,3-Diphosphoglycerate; Adenine; Adult; Aged; Blood Glucose; Blood Preservation; Erythrocyte Count; | 2017 |
Critical re-appraisal of blood component quality after overnight hold of whole blood outside current room temperature limits.
Topics: 2,3-Diphosphoglycerate; Adenosine Triphosphate; Blood Platelets; Blood Preservation; Erythrocytes; H | 2017 |
The effect of storing whole blood at 22 degrees C for up to 24 hours with and without rapid cooling on the quality of red cell concentrates and fresh-frozen plasma.
Topics: 2,3-Diphosphoglycerate; Adenosine Triphosphate; Blood Banks; Blood Preservation; Blood Proteins; Col | 2008 |
An improved red blood cell additive solution maintains 2,3-diphosphoglycerate and adenosine triphosphate levels by an enhancing effect on phosphofructokinase activity during cold storage.
Topics: 2,3-Diphosphoglycerate; Adenosine; Adenosine Triphosphate; Blood Preservation; Cryopreservation; Ery | 2010 |
Influence of irradiation on in vitro red-blood-cell (RBC) storage variables of leucoreduced RBCs in additive solution PAGGS-M.
Topics: 2,3-Diphosphoglycerate; Adenine; Adenosine Triphosphate; Blood Cell Count; Blood Preservation; Eryth | 2011 |
Characteristics of prion-filtered red cells suspended in pathogen-inactivated plasma (MB treated or solvent-detergent treated) for neonatal exchange transfusion.
Topics: 2,3-Diphosphoglycerate; Adenosine Triphosphate; alpha-2-Antiplasmin; Blood Preservation; Blood Prote | 2011 |
Effect of rate and delay of cooling during initial cooling process: in vitro effect on red cells.
Topics: 2,3-Diphosphoglycerate; Adenosine Triphosphate; Blood Preservation; Cold Temperature; Erythrocytes; | 2011 |
Evaluation of the properties of components prepared and stored after holding of whole blood units for 8 and 24 hours at ambient temperature.
Topics: 2,3-Diphosphoglycerate; Adenosine Triphosphate; Blood Coagulation Factors; Blood Component Removal; | 2011 |
Red cell concentrate storage and transport temperature.
Topics: 2,3-Diphosphoglycerate; Adenosine Triphosphate; Blood Preservation; Erythrocytes; Hemolysis; Humans; | 2011 |
Centrifugation after irradiation of red blood cells does not accelerate haemolysis.
Topics: 2,3-Diphosphoglycerate; Adenosine Triphosphate; Blood Glucose; Blood Preservation; Blood Transfusion | 2011 |
Effects of helicopter transport on red blood cell components.
Topics: 2,3-Diphosphoglycerate; Adenosine Triphosphate; Aircraft; Blood Preservation; Erythrocyte Transfusio | 2012 |
The 30 minute rule for red blood cells: in vitro quality assessment after repeated exposure to 30°C.
Topics: 2,3-Diphosphoglycerate; Adenosine Triphosphate; Blood Banks; Blood Preservation; Blood Specimen Coll | 2013 |
Alkaline CPD and the preservation of RBC 2,3-DPG.
Topics: 2,3-Diphosphoglycerate; Adenosine Triphosphate; Adult; Blood Preservation; Cell Survival; Citrates; | 2002 |
Improved maintenance of 2,3 DPG and ATP in RBCs stored in a modified additive solution.
Topics: 2,3-Diphosphoglycerate; Adenosine Triphosphate; Blood Preservation; Erythrocytes; Hematocrit; Hemoly | 2002 |
Twelve-week RBC storage.
Topics: 2,3-Diphosphoglycerate; Adenosine Triphosphate; Blood Donors; Blood Preservation; Erythrocyte Transf | 2003 |
Interlaboratory comparison of red-cell ATP, 2,3-diphosphoglycerate and haemolysis measurements.
Topics: 2,3-Diphosphoglycerate; Adenosine Triphosphate; Biomarkers; Blood Preservation; Erythrocyte Aging; E | 2005 |
Is it time to focus on preserving the functionality of red blood cells during storage?
Topics: 2,3-Diphosphoglycerate; Blood Preservation; Cell Survival; Erythrocyte Membrane; Erythrocytes; Gluco | 2006 |
Storage of red blood cells with improved maintenance of 2,3-bisphosphoglycerate.
Topics: 2,3-Diphosphoglycerate; Adenosine Triphosphate; Anticoagulants; Blood Preservation; Citrates; Erythr | 2006 |
Storage of equine red blood cells as a concentrate.
Topics: 2,3-Diphosphoglycerate; Adenosine Triphosphate; Animals; Blood Preservation; Erythrocytes; Hemolysis | 2008 |
The effects of preserved red blood cells on the severe adverse events observed in patients infused with hemoglobin based oxygen carriers.
Topics: 2,3-Diphosphoglycerate; Adenine; Adenosine Triphosphate; Anemia; Blood Preservation; Blood Substitut | 2008 |
Prolonged maintenance of 2,3-diphosphoglycerate acid and adenosine triphosphate in red blood cells during storage.
Topics: 2,3-Diphosphoglycerate; Adenosine Triphosphate; Blood Preservation; Cell Shape; Erythrocytes; Hemoly | 2008 |
Molecular aspects of embryonic mouse haemoglobin ontogeny.
Topics: 2,3-Diphosphoglycerate; Animals; Chromatography, Ion Exchange; Diphosphoglyceric Acids; Fetal Hemogl | 1983 |
Isoosmotic sucrose, adenine, inosine media for preservation of blood.
Topics: 2,3-Diphosphoglycerate; Adenine; Adenosine Triphosphate; Blood Preservation; Diphosphoglyceric Acids | 1983 |
Dehydrated hereditary stomatocytosis--a report of two families and a review of the literature.
Topics: 2,3-Diphosphoglycerate; Adult; Anemia, Hemolytic, Congenital; Anemia, Hemolytic, Congenital Nonspher | 1984 |
Storage of red cell concentrates in CPD-A2 for 42 and 49 days.
Topics: 2,3-Diphosphoglycerate; Adenine; Adenosine Triphosphate; Blood Preservation; Citrates; Diphosphoglyc | 1983 |
Cryopreservation of cyanate-treated sickle erythrocytes.
Topics: 2,3-Diphosphoglycerate; Adenosine Triphosphate; Anemia, Sickle Cell; Blood Preservation; Cyanates; D | 1982 |
Clinical problems in the use of blood and blood substitutes.
Topics: 2,3-Diphosphoglycerate; Blood; Blood Substitutes; Blood Transfusion, Autologous; Communicable Diseas | 1982 |
Half-strength citrate CPD and new additive solutions for improved blood preservation. I. Studies of six experimental solutions.
Topics: 2,3-Diphosphoglycerate; Adenine Nucleotides; Adenosine Triphosphate; Anticoagulants; Blood Preservat | 1993 |
Half-strength citrate CPD combined with a new additive solution for improved storage of red blood cells suitable for clinical use.
Topics: 2,3-Diphosphoglycerate; Blood Donors; Blood Preservation; Citrates; Diphosphoglyceric Acids; Erythro | 1993 |
Red cell alterations associated with virucidal methylene blue phototreatment.
Topics: 2,3-Diphosphoglycerate; Adenosine Triphosphate; Animals; Antiviral Agents; Blood Preservation; Dipho | 1993 |
Influence of ozone on haemoglobin oxygen affinity in type-2 diabetic patients with peripheral vascular disease: in vitro studies.
Topics: 2,3-Diphosphoglycerate; Case-Control Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diph | 1995 |
Physiological response to experimentally induced anemia in rats: a comparative study.
Topics: 2,3-Diphosphoglycerate; Anemia; Animals; Bone Marrow; Diphosphoglyceric Acids; Disease Models, Anima | 1995 |
Mechanisms of hemolysate-induced [Ca2+]i elevation in cerebral smooth muscle cells.
Topics: 2,3-Diphosphoglycerate; Animals; Basilar Artery; Calcium; Calcium Channel Blockers; Cytosol; Diphosp | 1995 |
Physical determinants of intermembrane protein transfer.
Topics: 2,3-Diphosphoglycerate; Adult; Anion Exchange Protein 1, Erythrocyte; Autoradiography; Calcium; Carb | 1996 |
[Effect of whole blood preparation and leukocyte filtration on storage of erythrocyte concentrates over 42 days].
Topics: 2,3-Diphosphoglycerate; Adenosine Triphosphate; Blood Preservation; Erythrocyte Transfusion; Filtrat | 1997 |
Intracellular hemoglobin S polymerization and the clinical severity of sickle cell anemia.
Topics: 2,3-Diphosphoglycerate; Adolescent; Adult; Anemia, Sickle Cell; Erythrocyte Indices; Erythrocytes; F | 1998 |
Improved blood preservation with 0.5CPD erythro-sol. Coagulation factor VIII activity and erythrocyte quality after delayed separation of blood.
Topics: 2,3-Diphosphoglycerate; Blood Preservation; Cell Separation; Citric Acid; Cold Temperature; Compleme | 1998 |
Preservation of red cell properties after virucidal phototreatment with dimethylmethylene blue.
Topics: 2,3-Diphosphoglycerate; Adenosine Triphosphate; Blood Preservation; Diarrhea Viruses, Bovine Viral; | 1998 |
Seroconversion of type B to O erythrocytes using recombinant Glycine max alpha-D-galactosidase.
Topics: 2,3-Diphosphoglycerate; ABO Blood-Group System; Adenosine Triphosphate; alpha-Galactosidase; Choline | 1998 |
Decreased hemolysis and lipid peroxidation in blood during storage in the presence of nicotinic acid.
Topics: 2,3-Diphosphoglycerate; Adenine; Adenosine Triphosphate; Blood Preservation; Citrates; Diethylhexyl | 1999 |
The effects of aged garlic extract on lipid peroxidation and the deformability of erythrocytes.
Topics: 2,3-Diphosphoglycerate; Adenosine Triphosphate; Animals; Antioxidants; Cells, Cultured; Dose-Respons | 2001 |
24-hour 51Cr post-transfusion survival, 51Cr life span and haemolysis of red blood cells stored at 4 degrees C for 56 days in AS-3.
Topics: 2,3-Diphosphoglycerate; Adenine; Adenosine Triphosphate; Adult; Anticoagulants; Blood Component Remo | 2001 |
Process for the preparation of pathogen-inactivated RBC concentrates by using PEN110 chemistry: preclinical studies.
Topics: 2,3-Diphosphoglycerate; Adenosine Triphosphate; Animals; Antigens, Surface; Aziridines; Blood Donors | 2002 |
Prestorage WBC filtration of RBC units with soft-shell filters: filtration performance and impact on RBCs during storage for 42 days.
Topics: 2,3-Diphosphoglycerate; Adenosine Triphosphate; Blood Component Removal; Blood Preservation; Erythro | 2002 |
Influence of the cryoprotective agents glycerol and hydroxyethyl starch on red blood cell ATP and 2,3-diphosphoglyceric acid levels.
Topics: 2,3-Diphosphoglycerate; Adenosine Triphosphate; Adult; Blood Preservation; Cryoprotective Agents; Di | 1992 |
Studies in red blood cell preservation. 5. Determining the limiting concentrations of NH4Cl and Na2HPO4 needed to maintain red blood cell ATP during storage.
Topics: 2,3-Diphosphoglycerate; Adenosine Triphosphate; Ammonia; Ammonium Chloride; Blood Preservation; Diph | 1992 |
[Improving the quality of washed and buffy coat-free erythrocyte concentrates].
Topics: 2,3-Diphosphoglycerate; Adenosine Triphosphate; Blood Cell Count; Blood Preservation; Cell Separatio | 1990 |
Storage of saline-adenine-glucose-mannitol-suspended red cells in a new plastic container: polyvinylchloride plasticized with butyryl-n-trihexyl-citrate.
Topics: 2,3-Diphosphoglycerate; Adenine; Adenine Nucleotides; Adenosine Triphosphate; Blood Glucose; Blood P | 1991 |
Biochemical changes in rat erythrocytes caused by ethylene oxide exposure.
Topics: 2,3-Diphosphoglycerate; Adenosine Triphosphate; Anemia, Macrocytic; Animals; Diphosphoglyceric Acids | 1990 |
Factors influencing the formation of methemoglobin in desferrioxamine loaded erythrocytes.
Topics: 2,3-Diphosphoglycerate; Deferoxamine; Diphosphoglyceric Acids; Erythrocytes; Hemolysis; Humans; Kine | 1990 |
[Viability of human red blood cells preserved for 35 days after leukocyte depletion (in vitro study)].
Topics: 2,3-Diphosphoglycerate; Adenosine Triphosphate; Blood Component Removal; Blood Glucose; Blood Preser | 1989 |
Activation by calcium of AMP deaminase from the human red cell.
Topics: 2,3-Diphosphoglycerate; Adenosine Triphosphate; AMP Deaminase; Calcium; Diphosphoglyceric Acids; Enz | 1989 |
The bottom and top system: a new technique for blood component preparation and storage.
Topics: 2,3-Diphosphoglycerate; Adenosine Monophosphate; Blood Cell Count; Blood Glucose; Blood Preservation | 1988 |
[Functional nonequivalency of the erythrocytes in donor blood in relation to their acid resistance].
Topics: 2,3-Diphosphoglycerate; Adenosine Triphosphate; Blood Donors; Blood Viscosity; Diphosphoglyceric Aci | 1988 |
Pressure increases oxygen affinity of whole blood and erythrocyte suspensions.
Topics: 2,3-Diphosphoglycerate; Adult; Diphosphoglyceric Acids; Erythrocytes; Hemoglobins; Hemolysis; Humans | 1986 |